Effect of self-administration versus provider-administered injection of subcutaneous depot medroxyprogesterone acetate on continuation rates in Malawi: a randomised controlled trial

Effect of self-administration versus provider-administered injection of subcutaneous depot medroxyprogesterone acetate on continuation rates in Malawi: a randomised controlled trial

Summary: Background: Injectable contraceptives are popular in sub-Saharan Africa but have high discontinuation rates due partly to the need for provider-administered re-injection. We compared continuation rates of women who self-injected subcutaneous depot medroxyprogesterone acetate (DMPA-SC) and...

Full description

Bibliographic Details
Main Authors: Holly M Burke, PhD, Mario Chen, PhD, Mercy Buluzi, BSc, Rachael Fuchs, MS, Silver Wevill, MPH, Lalitha Venkatasubramanian, BS, Leila Dal Santo, MPH, Bagrey Ngwira, PhD
Format: Article
Language:English
Published: Elsevier 2018-05-01
Series:The Lancet Global Health
Online Access:http://www.sciencedirect.com/science/article/pii/S2214109X18300615

Internet

http://www.sciencedirect.com/science/article/pii/S2214109X18300615

Similar Items